These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 12068137)
1. Survival benefits of lung cancer patients undergoing laser and brachytherapy. Jang TW; Blackman G; George JJ J Korean Med Sci; 2002 Jun; 17(3):341-7. PubMed ID: 12068137 [TBL] [Abstract][Full Text] [Related]
2. Combination of interventional pulmonology techniques (Nd:YAG laser resection and brachytherapy) with external beam radiotherapy in the treatment of lung cancer patients with Karnofsky Index < or =50. Canak V; Zarić B; Milovancev A; Jovanović S; Budisin E; Sarcev T; Lalić N; Nisević V; Balaban G J BUON; 2006; 11(4):447-56. PubMed ID: 17309176 [TBL] [Abstract][Full Text] [Related]
3. Long-term clinical benefits of the low dose rate endobronchial irradiation of malignant airway obstructions. Spásová I; Petera J Neoplasma; 2001; 48(3):234-40. PubMed ID: 11583295 [TBL] [Abstract][Full Text] [Related]
4. Endobronchial radiation therapy for obstructing malignancies: ten years' experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients. Macha HN; Wahlers B; Reichle C; von Zwehl D Lung; 1995; 173(5):271-80. PubMed ID: 7564485 [TBL] [Abstract][Full Text] [Related]
6. [The results of the endoluminal high-dose-rate irradiation of central non-small cell bronchial carcinomas]. Schraube P; Fritz P; Becker HD; Wannenmacher M Strahlenther Onkol; 1993 Apr; 169(4):228-34. PubMed ID: 8387698 [TBL] [Abstract][Full Text] [Related]
7. Endobronchial brachytherapy with high-dose-rate remote afterloading for recurrent endobronchial lesions. Delclos ME; Komaki R; Morice RC; Allen PK; Davis M; Garden A Radiology; 1996 Oct; 201(1):279-82. PubMed ID: 8816560 [TBL] [Abstract][Full Text] [Related]
8. Neodymium:YAG laser and brachytherapy in the management of inoperable bronchogenic carcinoma. Miller JI; Phillips TW Ann Thorac Surg; 1990 Aug; 50(2):190-5; discussion 195-6. PubMed ID: 1696452 [TBL] [Abstract][Full Text] [Related]
9. Endobronchial brachytherapy and optimization of local disease control in medically inoperable non-small cell lung carcinoma: a matched-pair analysis. Mantz CA; Dosoretz DE; Rubenstein JH; Blitzer PH; Katin MJ; Garton GR; Nakfoor BM; Siegel AD; Tolep KA; Hannan SE; Dosani R; Feroz A; Maas C; Bhat S; Panjikaran G; Lalla S; Belani K; Ross RH Brachytherapy; 2004; 3(4):183-90. PubMed ID: 15607149 [TBL] [Abstract][Full Text] [Related]
10. The use of high dose rate endobronchial brachytherapy to palliate symptomatic recurrence of previously irriadiated lung cancer. Kubaszewska M; Skowronek J; Chicheł A; Kanikowski M Neoplasma; 2008; 55(3):239-45. PubMed ID: 18348661 [TBL] [Abstract][Full Text] [Related]
11. [The role of high dose rate (HDR) brachytherapy in advanced non-small cell lung cancer]. Makarewicz R Pneumonol Alergol Pol; 2002; 70(5-6):265-77. PubMed ID: 12518625 [TBL] [Abstract][Full Text] [Related]
12. A pilot clinical laboratory trial of paclitaxel and endobronchial brachytherapy in patients with non-small cell lung cancer. Lee JS; Komaki R; Morice RC; Ro JY; Kalapurakal SK; Schea R; Murphy WK; Shin DM; Fox NT; Walsh GL; Hittelman WN; Hong WK Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):121-9. PubMed ID: 10210551 [TBL] [Abstract][Full Text] [Related]
13. [Recent advances in radiation therapy for non-small cell lung cancer]. Morita K Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():103-6. PubMed ID: 9216195 [TBL] [Abstract][Full Text] [Related]
14. The effect of Nd:YAG laser resection on symptom control, time to progression and survival in lung cancer patients. Zaric B; Canak V; Milovancev A; Jovanovic S; Budisin E; Sarcev T; Nisevic V J BUON; 2007; 12(3):361-8. PubMed ID: 17918290 [TBL] [Abstract][Full Text] [Related]
15. Survival of patients undergoing Nd:YAG laser therapy compared with Nd:YAG laser therapy and brachytherapy for malignant airway disease. Shea JM; Allen RP; Tharratt RS; Chan AL; Siefkin AD Chest; 1993 Apr; 103(4):1028-31. PubMed ID: 7510598 [TBL] [Abstract][Full Text] [Related]
16. Anatomic segmentectomy and brachytherapy mesh implantation for clinical stage I non-small cell lung cancer (NSCLC). Landreneau JP; Schuchert MJ; Weyant R; Abbas G; Wizorek JJ; Awais O; Reamer MM; Luketich JD; Landreneau RJ Surgery; 2014 Feb; 155(2):340-6. PubMed ID: 24314884 [TBL] [Abstract][Full Text] [Related]
17. CT-guided interstitial brachytherapy of inoperable non-small cell lung cancer. Wang ZM; Lu J; Liu T; Chen KM; Huang G; Liu FJ Lung Cancer; 2011 Nov; 74(2):253-7. PubMed ID: 21513997 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470 [TBL] [Abstract][Full Text] [Related]
19. High dose rate endobronchial brachytherapy in the management of lung cancer: response and toxicity evaluation in 158 patients. Ozkok S; Karakoyun-Celik O; Goksel T; Mogulkoc N; Yalman D; Gok G; Bolukbasi Y Lung Cancer; 2008 Dec; 62(3):326-33. PubMed ID: 18482780 [TBL] [Abstract][Full Text] [Related]
20. Combined Nd-YAG laser/HDR brachytherapy versus Nd-YAG laser only in malignant central airway involvement: a prospective randomized study. Chella A; Ambrogi MC; Ribechini A; Mussi A; Fabrini MG; Silvano G; Cionini L; Angeletti CA Lung Cancer; 2000 Mar; 27(3):169-75. PubMed ID: 10699690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]